whether disseminated cancer cells colonize a certain site, without influencing the selection of cells that are able to disseminate from the primary site? There is also evidence for the role of WNT signalling in the formation of pre-metastatic niches that direct and nurture metastasizing tumour cells, and it would be interesting to know how this aspect fits into the picture 4 . A major challenge in these studies is the complexity of WNT signalling, which involves a large number of ligands (both agonists and antagonists) and receptors/co-receptors. Clarifying this signalling may explain why DKK1 blocks non-canonical pathways in the lung and the canonical pathway in the bone. Thus, although Zhuang et al. and other studies have shown that WNT signalling has roles in many aspects of the metastatic cascade, there is still much more to understand about signalling at individual steps and in different organs. Nevertheless, the study by Zhuang et al. is an excellent example that metastasis should be considered as a systemic disease, and that understanding the molecular mechanisms within the local tumour microenvironment, in addition to the phenotypic characterization of cancer cells, represents the key to rational therapeutic designs. Consistent with this view, combinatorial inhibition of JNK and TGF-β effectively suppressed both lung and bone metastasis (Fig. 1) .
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Whether in high school classrooms or scholarly journals, schematics generally depict the nucleus as a circle that sits in the centre of a cell. In real cells, however, nuclei often have specific subcellular localizations. Developing skeletal muscle cells, which can contain hundreds of nuclei each, provide an extraordinary system for investigating nuclear positioning. In healthy myofibres (fully differentiated muscle cells), nuclei are positioned around the cell periphery. In certain diseases, such as centronuclear myopathies (CNM), nuclei are instead found in the cell interior 1 . These observations made by pathologists, combined with recent mutant analyses in model systems, have contributed to a growing appreciation that correct myonuclear positioning is essential for muscle function 2 . But what mechanisms normally localize nuclei to the fibre periphery? And why do these mechanisms fail in CNM? In this issue of Nature Cell Biology, Gomes and colleagues 3 report a mechanism for the peripheral movement of myonuclei: centripetal forces exerted by the crosslinking and contraction of myofibrils squeeze nuclei from the fibre centre to the periphery.
Over the course of muscle development, nuclei undergo a series of discrete movements to arrive at their ultimate destination, the fibre periphery (Fig. 1) . Multinucleated muscle cells form by the iterative fusion of myoblasts (mononucleated muscle precursor cells) to the growing myotube. Following fusion, each newly added nucleus travels from the periphery to a growing cluster of nuclei in the centre of the myotube. Next, the nuclei spread out and become evenly spaced along the longitudinal axis of the cell, remaining in the crosssectional centre. Then, nuclei travel back from the fibre centre to the periphery, where they then remain 4 . In recent years, the Gomes lab has studied the molecular mechanisms underlying myonuclear movement using in vitro systems. As with other examples of nuclear positioning, the main players in myonuclear positioning are cytoskeletal components. Interestingly, however, the cytoskeleton-based mechanisms of nuclear positioning differ for each phase of nuclear movement. The initial movement of nuclei to the centre of the myotube following fusion requires microtubules, the microtubule motor Dynein, Cdc42, Par6 and Par3
5
.
The subsequent spreading of nuclei along the myotube's long axis also requires microtubules, but the motors and microtubuleassociated proteins (MAPs) are different; this phase requires Kinesin and MAP7 (also known as Ensconsin) 2 . Interestingly, the next step of nuclear movement -from the myotube centre to the periphery -occurs by a completely different mechanism. Here, microtubules are dispensable. Instead, peripheral nuclear movement requires actin, the actin nucleation promoter N-WASP (neural Wiskott-Aldrich syndrome protein), and the N-WASP regulator Amphiphysin-2 (Amph2) 6 . Although elucidating the N-WASP-Amph2-actin pathway for peripheral nuclear movement was exciting, the underlying molecular mechanism remained mysterious. Now Gomes and colleagues investigate how actin and its regulators drive peripheral nuclear movement and propose a previously unappreciated mechanism: extrusion of nuclei from the myofibre centre by the physical forces exerted by myofibrils (Fig. 2 ). This conclusion is partly based on spinning disk microscopy time-lapse images that track nuclei and myofibrils during peripheral movement. Before peripheral movement, myofibrils are present in the fibre, but are absent from a longitudinal stretch surrounding the nucleus. Then, immediately before peripheral nuclear movement, myofibrils on either side of this gap crosslink in an orderly progression, starting from the positions furthest from the nucleus. Similarly to a zip, the cross-linking then spreads from both sides towards the nucleus, ultimately squeezing the nucleus out of that plane and into the cell periphery. During this process, the nucleus undergoes deformations that reflect the forces being applied to it.
The authors use siRNA-mediated knockdown and other molecular approaches to mechanistically define how myofibril 'zipping' occurs. They find that the intermediate filament protein Desmin is essential for the myofibril crosslinking that contributes to nuclear extrusion. How are Desmin filaments properly localized at Z-lines to perform this function? Knockdown experiments show that Desmin organization at the Z-line requires γ-actin and the Arp2/3 actin nucleation complex component Arpc5L, which co-immunoprecipitate and co-localize; knockdown of either prevents peripheral nuclear movement. Arp2/3 is regulated by N-WASP, which the Gomes lab has previously shown is essential for peripheral nuclear movement, along with the N-WASP regulator Amph2 6 . Thus, this paper extends the actin pathway previously shown to be essential for nuclear movement to the periphery, and defines its mechanism of action.
Along with their experimental work, the authors also mathematically model peripheral nuclear movement. Their model predicts that the myofibrils' activity as molecular zippers is not sufficient for nuclear extrusion from the centre: there must also be an increase in myofibril tension. Reasoning that this tension is likely to be caused by muscle contraction, the authors experimentally block muscle contraction with tetrodotoxin and observe an inhibition of peripheral nuclear movement. Moreover, through the use of optogenetics, they find that inducing contractions early in myofibre development causes precocious peripheral movement. Thus, contraction is necessary and sufficient for peripheral nuclear movement.
Although it is impossible to know why this unusual mechanism evolved, one possibility is that it has value as a timing mechanism for muscle development. Because myofibril contractions can only occur after myofibre differentiation, this mechanism may ensure that nuclei will not travel to the periphery too early. It stands to reason that precocious peripheral movement could interrupt the previous phase of nuclear positioninglongitudinal spreading -and lead to myofibres with peripheral nuclei that are clustered along the longitudinal axis of the fibre. Certain Drosophila melanogaster and mouse mutants have been described that have clustered rather than evenly spread nuclei, and they all exhibit functional muscle deficits 2, [7] [8] [9] [10] . The Gomes lab previously showed that inhibition of microtubule/Kinesin/MAP7-dependent nuclear spreading ultimately prevents peripheral nuclear movement, even though that pathway is not required for peripheral movement per se -which led them to conclude that longitudinal nuclear spreading must occur before peripheral movement can take place 6 . This suggests that either myofibres lacking Kinesin or MAP7 cannot generate the force required to extrude nuclei to the periphery, or there are additional mechanisms ensuring the orderly progression of myonuclear movement.
The mechanisms of peripheral nuclear movement uncovered in this paper explain how nuclei can be left behind in the fibre's 
MK2 balances inflammation and cell death

Andrew Oberst
The cytokine tumour necrosis factor (TNF) and the toll-like receptors (TLRs) coordinate immune responses by activating inflammatory transcriptional programs, but these signals can also trigger cell death. Recent studies identify the MAP kinase substrate MK2 as a key player in determining whether cells live or die in response to TNF and TLR signalling.
Activation of the TLRs by pathogen-associated molecular patterns (PAMPs), and subsequent production of the cytokine TNF, are key events in the initiation of immune responses 1 . Cells respond to TLR ligands or TNF by initiating inflammatory transcription programsthrough NF-κB, MAP kinases or interferon regulatory factor (IRF) pathways -which lead to the expression of chemokines and cytokines that propagate and coordinate the immune response, as well as the activation of cell-autonomous immune defences. Pathogens have evolved to counter these key signalling pathways. Cells in which pathogen-encoded inhibitors are present represent a double liability for the host: not only are they prevented from participating in the immune response, they may act as hiding places or replicative niches for the pathogens themselves. In short, if a cell receives an inflammatory stimulus but cannot respond properly, it needs to kill itself.
To achieve this, TNF and TLR signalling engages RIPK1, which can both initiate inflammatory transcription and trigger cell death 2 . These two cell fates are elegantly linked, because the cell-killing functions of RIPK1 are held in check by components of the inflammatory signalling pathways themselves. Thus, if the pathways leading to a protective inflammatory response are interfered withby, for example, a pathogen effector protein -RIPK1 is unleashed to kill the cell. Three recent studies identify the kinase MAPKAP kinase-2 (MK2) as a 'safety catch' on RIPK1, keeping cells alive as long as they are productive participants in the immune response [3] [4] [5] . In this issue of Nature Cell Biology, Menon et al. 3 and Dondelinger et al. 4 show that MK2 phosphorylates RIPK1 to regulate TNF-mediated cell death and RIPK1 signalling in inflammation and bacterial infection (Fig. 1) .
To understand MK2 function, we must first understand how cells respond to TNF. TNF can centre. An open question is how such peripheral mispositioning of myonuclei affects muscle function. By defining a molecular pathway for peripheral nuclear movement, Gomes and colleagues are also expanding the toolkit available to researchers working on this question; the more precisely we can manipulate nuclear movements, the better we can characterize the downstream consequences. Ultimately, we will be able to explain not only how each stage of myonuclear movement occurs, but also how mispositioning affects both the mispositioned myonuclei and the myofibre as a whole.
The findings of Gomes and colleagues also shed light on CNM. The disorder is caused by mutations in a number of genes, including Amph2 11 . The block in peripheral nuclear movement observed following depletion of Amph2 (or the other components of this actin pathway) recapitulates the centrally located nuclei observed in muscle samples from patients with CNM. Although it has not been tested, it is highly plausible that myofibril zipping fails in CNM muscle, leading to the accumulation of centrally located myonuclei. The authors show that nuclear deformation and protrusion occur during peripheral nuclear movement in mouse in vivo; in the future, it will be fascinating to observe to what extent their other observations and conclusions about normal nuclear movement are recapitulated in vivo, especially in human muscle. In the same way, it will be essential to know to what extent the defects they see in siRNA-treated muscle in vitro recapitulate the cell biology of human CNM muscle.
Finally, it is interesting to consider whether the mechanism of peripheral movement by physical extrusion could be relevant to other muscle diseases. In muscle disorders such as nemaline myopathy, muscle contraction is impaired 12 . Is peripheral nuclear movement similarly affected? The mathematical modelling performed by Gomes and colleagues also predicts that nuclei must have a certain stiffness to be extruded properly, and they validate this experimentally by overexpressing Lamin A/C to increase stiffness or knocking down Lamin A/C to decrease stiffness; both manipulations inhibit peripheral nuclear movement. Certain mutations in Lamin cause Emery-Dreifuss muscular dystrophy (EDMD), and in some cases myonuclei have diminished stiffness 13 . Does peripheral nuclear movement fail here as well?
In the future it will be exciting to gain a better understanding of how intracellular mechanical properties are affected in various muscle diseases, and what the downstream consequences are for muscle structure and function.
